TNXP (tonixpharma.com) Bozor qiymatining balans qiymatiga nisbati

Tonix Pharma (TNXP) kompaniyasining rasmiy ramzlari

Tonix Pharmaceuticals (TNXP) uchun ushbu narxlar grafigi immun tizimi buzilishlari va markaziy nerv tizimi patologiyalarini, jumladan, virusli tahdidlar va fibromialgiya bilan kurashishga qaratilgan davolash vositalarini ishlab chiqishga e'tibor qaratgan aktivning narxlar dinamikasini aks ettiradi. Indikator 0.41 darajasida turibdi. O'sish FDA tasdiqlari va mavjud R&D kapitali hisobiga ta'minlanmoqda, garchi dori vositalarini sinovdan o'tkazishning joriy bosqichlarining spekulyativ tabiati tufayli portfel binar xatarlarga duchor bo'lishi mumkin bo'lsa-da.

TNXP Tonix Pharmaceuticals Holding: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Tonix Pharma (TNXP) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Tonix Pharmaceuticals|TNXP - Prognoz darajalari grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Tonix Pharmaceuticals Inc.|TNXP - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Tonix Pharmaceuticals|TNXP - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati tonixpharma.com|TNXP - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Tonix Pharmaceuticals|TNXP - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Tonix Pharmaceuticals Inc.|TNXP - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Tonix Pharmaceuticals Inc.|TNXP - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Tonix Pharmaceuticals
Kompaniyaning dastlabki tahlili:Tonix Pharmaceuticals - TNXP
Tonix Pharmaceuticals Inc. original mahsuloti

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlariga solishtiradi, bu esa aksiyalar haqiqiy kapitalga nisbatan haddan tashqari qimmat yoki arzon baholanganini aniqlash imkonini beradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatidagi tendentsiyasini tahlil qilish orqali investor vaksinalar va markaziy nerv tizimi (CNS) dori vositalari sohasidagi tadqiqot va ishlanmalar (R&D) yuqori xarajatlarini hisobga olgan holda Tonix Pharmaceuticals (TNXP) uchun kirish nuqtalarini aniqlashi mumkin.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Haleon plc (HLN)|KVUE (kenvue.com) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ipatherapeutics.com HYFT|Kapitallashuvning sof aktivlarga nisbati ABVC BioPharma, Inc. (ABVC)|Cumberland Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga multiplikatori|QNTM (Quantum BioPharma Limited) - Bozor qiymatining balans qiymatiga nisbati|FGEN: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals|Rani Therapeutics Holdings, Inc. (RANI) - Kapitallashuvning balans qiymatiga nisbati|SNYR: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Rallybio Corp. (RLYB)|Kapitallashuvning sof aktivlarga nisbati Lexaria Bioscience LEXX|Kapitallashuvning balans qiymatiga nisbati Pulmatrix Corporation PULM|Kapitallashuvning sof aktivlarga nisbati Pheton Holdings|Aptorum Group Ltd - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Lyra Therapeutics|IBO - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati tnfpharma.com TNFA|cbdMD (YCBD) - Balans qiymatiga nisbatan bozor qiymati|PRFX (PainReform Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati CYTO|Lipella Pharmaceuticals, Inc. (LIPO) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati OPTN (OptiNose Inc)|Pieris - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Procaps Group Corp PROC|Petros Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|QLI - Bozor kapitallashuvining balans qiymatiga nisbati|SLRN (ACELYRIN) - Bozor kapitallashuvining balans qiymatiga nisbati|TFF Pharmaceuticals Inc. (TFFP) - Kapitallashuvning sof aktivlarga nisbati